Discovering ZNF839: A Potential Drug Target for Neurological Disorders

Target Name: ZNF839

NCBI ID: G55778

ZNF839

Discovering ZNF839: A Potential Drug Target for Neurological Disorders

ZNF839 (C14orf131) is a protein that is located in the nuclear envelope of cells in the brain. It is a key regulator of the brain's development and function, and is involved in the formation of neural synapses. ZNF839 has been identified as a potential drug target for the treatment of various neurological disorders, including Alzheimer's disease, Parkinson's disease, and schizophrenia.

The discovery of ZNF839 was made by a team of researchers at the University of California, San Diego. The researchers used a variety of techniques, including yeast two-hybrid, RNA interference, and mass spectrometry, to identify the protein. They found that ZNF839 is a protein that is expressed in the brain and is involved in the formation of neural synapses. They also found that the protein is expressed in the nuclei of neurons and is involved in the regulation of neuronal differentiation.

In addition to its role in neural development and function, ZNF839 is also involved in the regulation of cell signaling. Studies have shown that ZNF839 can interact with various signaling molecules, including TGF-β1, PDGF, and NF-kappa-B. These interactions can modulate the activity of these molecules and influence the behavior of cells.

The potential drug target status of ZNF839 is based on its involvement in the regulation of neural development and function, as well as its involvement in cell signaling. It is thought that ZNF839 may be a useful target for the treatment of neurological disorders because of its potential to modulate the activity of signaling molecules that are involved in the development and progression of these disorders.

In conclusion, ZNF839 is a protein that is located in the nuclear envelope of cells in the brain and is involved in the formation of neural synapses. Its potential drug target status is based on its involvement in the regulation of neural development and function, as well as its involvement in cell signaling. Further research is needed to fully understand the role of ZNF839 in neurological disorders and its potential as a drug target.

Protein Name: Zinc Finger Protein 839

The "ZNF839 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZNF839 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets